Explore the latest insights and case studies on different approaches to clinical trial assay development, validation, and deployment in trials for both oncology and chronic disease indications from both a biopharma and diagnostics perspective.

This webinar will cover several key topics related to biomarker-driven clinical trials. Attendees will learn how to maximize success in these types of trials globally, with a specific focus on the importance of China. Additionally, there will be a discussion on the regulatory challenges associated with the latest thinking on IVDR Europe.

Join this webinar to get an in-depth look at the opportunities and challenges of clinical trial assay development & validation and the critical steps involved to ensure that they are ready for stratification use within clinical trials.

What You Will Learn

Attendees will:

• Hear from both AstraZeneca and Boehringer Ingelheim on their approach to clinical trial assay development, validation and deployment in clinical trials for both oncology and chronic disease indications
• Hear from Almac on differing approaches to clinical trial assay development & validation in the lab relating to specific disease indications and intended use
• Explore how to maximise the success of biomarker driven clinical trials globally, including a focus on the importance of China
• Discuss regulatory challenges around the latest thinking on IVDR Europe

Speakers: